000			03485nam a22003974u 4500
001			10.1002/9781394159338
003			Wiley
005			20251030120316.0
007			cr nn 008mam|a
008			240701t2024||||xxu fs| |0|| 0|eng||
020			_a9781394159338 _qelectronic
024	7		_a10.1002/9781394159338 _2doi
041			_aeng
245	0	0	_aDrug Delivery Systems Using Quantum Computing _h[electronic resource] _cEdited by Rishabha Malviya, Sonali Sundram, Dhanalekshmi Unnikrishnan Meenakshi.
250			_a1
260			_bWiley _c2024
264		1	_bWiley _c2024
300			_a480pp.;
336			_atext _btxt _2rdacontent
337			_acomputer _bc _2rdamedia
338			_aonline resource _bcr _2rdacarrier
347			_atext file _2rdaft
347			_bPDF
520			_aThe first book of its kind to show the potential of quantum computing in drug delivery. Drug delivery systems (DDS) are defined as methods by which drugs are delivered to desired tissues, organs, cells, and subcellular organs for drug release and absorption through a variety of drug carriers. By controlling the precise level and/or location of a given drug in the body, side effects are reduced, doses are lowered, and new therapies are possible. Nevertheless, there are still significant obstacles to delivering certain medications to particular cells. Drug delivery methods change pharmacokinetic, pharmacodynamic, and drug release patterns to enhance product efficacy and safety, as well as patient convenience and compliance. Computational approaches in drug development enable quick screening of a vast chemical library and identification of possible binders by using modeling, simulation, and visualization tools. Quantum computing (QC) is a fundamentally new computing paradigm based on quantum mechanics rules that enables certain computations to be conducted significantly more rapidly and effectively than regular computing, and hence this has huge promise for the pharmaceutical sector. Significant advances in computational simulation are making it easier to comprehend the process of drug delivery. This book explores an important biophysical component of DDSs, and how computer modeling may help with the logical design of DDSs with enhanced and optimized characteristics. The book concentrates on computational research for various important types of nanocarriers, including dendrimers and dendrons, polymers, peptides, nucleic acids, lipids, carbon-based DDSs, and gold nanoparticles. Audience Researchers and industry scientists working in clinical research and disease management; pharmacists, formulation and pharmaceutical scientists working in R&D; computer science engineers applying deep learning and quantum computing in healthcare.
650		4	_aDrug Formulation & Delivery _991495
650		4	_aQuantum Computing _964754
650		4	_aPharmacology & Pharmaceutical Medicine _991316
700	1		_aMalviya, Rishabha _4edt _965301
700	1		_aSundram, Sonali _4edt _965302
700	1		_aMeenakshi, Dhanalekshmi Unnikrishnan _4edt _991862
776	0	8	_iPrinted edition: _z9781394159147
856	4	0	_uhttps://doi.org/10.1002/9781394159338 _aWiley Online Library
856	4	0	_uhttps://onlinelibrary.wiley.com/action/showBook?doi=10.1002%2F9781394159338 _aWiley Online Library
856	4	2	_3Cover Image _uhttps://onlinelibrary.wiley.com/cms/asset/0334fd34-f952-4289-9619-2f382e68e80b/9781394159338.cover.gif _aWiley Online Library
999			_c67198 _d67198